Effect of Toothpaste on the Reduction of Plaque and Inflammation
Clinical Evaluation of the Effect of an Experimental Toothpaste on the Reduction of Dental Plaque and Gingival Inflammation
研究概览
详细说明
Before study start, investigators and study nurses will be trained on how to apply SOPs, parameters, and adverse event management. On-site monitoring will be done by the sponsor after recruitment, after visit 2 and after the final visit.
All source data will be entered in paper CRFs. For the statistical analysis these data will be entered into the data bank via double data entry. Programmed range checks, validity checks, consistency checks, and manual/visual data checks for medicinal plausibility will be done before the blind data review meeting. During blind data review meeting minor protocol violations will be recorded and assessed. No imputation of missing data will be done for ITT or PP analyses.
The sample size estimation was carried out by means of one-sided unpaired t-test with a one-sided significance level of α=0.05. For testing superiority of the test product over negative control, the investigators test the hypothesis, H0: μTest product - μNegative control ≤ 0 H1: μTest product - μNegative control > 0 by using a one-sided t-test with α=0.05. A relevant difference of Δ=0.14 and a standard deviation of σ=0.4 was assumed based on previous studies. When estimating a drop-out rate of about 20 % a total of 120 = 102 + 18 subjects per group will be assigned at study start. Drop-outs will not be replaced during the study.
The primary parameter is the difference of plaque index between baseline (V1) value and the value after 12 weeks +/- 5 days (V3) of product use. For primary statistical analysis, a t-tests (unpaired situation) will be performed at a one-sided significance level of α=0.05. The primary efficacy analysis will be performed on the ITT-analysis set.
Secondary variables will be assessed with t-tests and confidence intervals to compare differences between V2, V3, and baseline for test product group and negative control group. Descriptive statistics will be performed for oral examinations for each group (counts and percentages of scores for nominal and ordinal scaled data, for at least ordinal scaled data minimum, maximum, median, mean value and standard deviation).
A two-sided significance level of α=0.05 is chosen for all secondary analyses, no adjustment for multiplicity will be done. Safety assessments will be based mainly on the frequency of adverse events.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Dresden、德国、01307
- Technische Universität Dresden
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Male and female adults (aged 18 to 65 years),
- Individuals with gingival inflammation, mean full-mouth GI ≥ 1.2 at inclusion,
- Individuals with plaque, mean full-mouth PI ≥ 1.2 at inclusion,
- Non-smokers or former smokers for at least 1 year or occasional smokers with a maximum of 5 cigarettes per week,
- Individuals who have at least 20 own teeth excluding the wisdom teeth,
- Subjects must have read, understood and signed the informed consent form
- Willingness to abstain from use of interdental brushing devices that contain antibacterial agents, like amine fluoride, chlorhexidine, silver ions etc. during the full course of the study
Exclusion Criteria:
- Individuals who have severe systemic diseases (tumors, infectious diseases) and diseases that require regular systemic medication intake that may affect the gingival condition (e. g. phenytoin, nifedipine, cyclosporine, antibiotics, steroids, antiphlogistics)
- Individuals who have moderate and severe chronic or aggressive periodontitis (PSI > 2 in more than 2 sextants or PSI > 3),
- Individuals who require antibiotic treatments for dental appointments (endocarditis prophylaxis), Individuals treated with antibiotics less than 8 weeks prior to the baseline examination and/or during the duration of the trial,
- Individuals who have participated in another clinical study less than 4 weeks prior to the baseline examination,
- Individuals who have mucosal diseases,
- Individuals who have severe oro-pharyngeal infections,
- Individuals who have significant dental disorders (e.g.: caries, suspected pulp pathology, abscess, pulpitis),
- History of gingival surgery in the previous three month,
- Ongoing dental treatment or any other medical treatment of the oral cavity,
- Individuals who are pregnant or breast feeding,
- Individuals with a history of chronic drug abuse or another illness which does not allow the person to assess the nature and/or possible consequences of the study,
- Smokers with more than 5 cigarettes per week,
- Individuals with known hypersensitivity or allergy to the test products and its ingredients,
- Individuals who were treated with antibacterial mouthrinses (e. g. chlorhexidine) 4 weeks or less before recruitment,
- Individuals unwilling to abstain from additional oral hygiene measures during the treatment phase with exception of their habitual mechanical cleaning procedures,
- Non-Caucasians,
- Subjects can be excluded at the principal investigators discretion.
学习计划
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Test group
Amine fluoride toothpaste
|
toothpaste
|
|
安慰剂比较：Control group
Placebo Sodium monofluorophosphate toothpaste
|
toothpaste
其他名称：
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Plaque index (Silness and Loe 1964)
大体时间：Change in plaque index from baseline at 12 weeks
|
Difference of plaque index, compared between test group and control group.
|
Change in plaque index from baseline at 12 weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Plaque index (Silness and Loe 1964)
大体时间：Change in plaque index from baseline at 3 weeks
|
Difference of plaque index, compared between test group and control group.
|
Change in plaque index from baseline at 3 weeks
|
|
Plaque index (Silness and Loe 1964)
大体时间：Change in plaque index from week 3 at 12 weeks
|
Difference of plaque index, compared between test group and control group.
|
Change in plaque index from week 3 at 12 weeks
|
|
Gingival Index (Loe 1967)
大体时间：Change in gingival index from baseline at 3 weeks
|
Difference of gingival index, compared between test group and control group.
|
Change in gingival index from baseline at 3 weeks
|
|
Gingival Index (Loe 1967)
大体时间：Change in gingival index from baseline at 12 weeks
|
Difference of gingival index, compared between test group and control group.
|
Change in gingival index from baseline at 12 weeks
|
|
Gingival Index (Loe 1967)
大体时间：Change in gingival index from 3 weeks at week 12
|
Difference of gingival index, compared between test group and control group.
|
Change in gingival index from 3 weeks at week 12
|
|
Modified Sulcus Bleeding Index (Muhlemann and Son 1971):
大体时间：Change in bleeding index from baseline at 12 weeks
|
Difference of bleeding index, compared between test group and control group.
|
Change in bleeding index from baseline at 12 weeks
|
|
Modified Sulcus Bleeding Index (Muhlemann and Son 1971):
大体时间：Change in bleeding index from baseline at week 3
|
Difference of bleeding index, compared between test group and control group.
|
Change in bleeding index from baseline at week 3
|
|
Modified Sulcus Bleeding Index (Muhlemann and Son 1971):
大体时间：Change in bleeding index from week 3 at week 12
|
Difference of bleeding index, compared between test group and control group.
|
Change in bleeding index from week 3 at week 12
|
|
Adverse events
大体时间：up to 12 weeks from baseline
|
List all
|
up to 12 weeks from baseline
|
合作者和调查者
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.